Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 08-2021 | 08-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,826 | -9,289 | -10,083 | -7,437 | -4,655 |
| Accounts payable and accrued liabilities | 31 | -23 | 33 | N/A | N/A |
| Other Working Capital | 907 | 663 | -215 | -242 | -43 |
| Other Operating Activity | 538 | 442 | 2,257 | 1,538 | 351 |
| Operating Cash Flow | $-8,350 | $-8,207 | $-8,008 | $-6,141 | $-4,347 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -481 | -12,173 | -12,699 | -6,098 | N/A |
| Sale Of Investment | 8,250 | 15,680 | 15,657 | 2,659 | N/A |
| Investing Cash Flow | $7,769 | $3,507 | $2,958 | $-3,439 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 112 | 567 | N/A | 14,119 | 1,978 |
| Other Financing Activity | 0 | 0 | 0 | -7 | 3 |
| Financing Cash Flow | $112 | $567 | $N/A | $14,112 | $1,981 |
| Exchange Rate Effect | -8 | 60 | -224 | -45 | 84 |
| Beginning Cash Position | 2,815 | 6,888 | 12,162 | 2,142 | 4,424 |
| End Cash Position | 2,338 | 2,815 | 6,888 | 6,629 | 2,142 |
| Net Cash Flow | $-477 | $-4,073 | $-5,274 | $4,487 | $-2,282 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,350 | -8,207 | -8,008 | -6,141 | -4,347 |
| Free Cash Flow | -8,350 | -8,207 | -8,008 | -6,141 | -4,347 |